Related Experiment Videos
[Multiple bone myelomas]
1Hématologie clinique, centre hospitalier universitaire, 44093 Nantes. philippe.moreau@chu-nantes.fr
La Revue Du Praticien
|June 3, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Monoclonal antibodies as an addition to current myeloma therapy strategies.
Expert review of anticancer therapy·2020
Same author
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials.
European journal of nuclear medicine and molecular imaging·2020
Same author
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft.
Scientific reports·2020
Same author
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials.
Cancers·2020
Same author
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse.
Leukemia·2020
Same author
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.
Blood cancer journal·2020
Same journal
[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].
La Revue du praticien·2026